课题基金 / 基金详情

肺癌の免疫治療における腫瘍免疫機能とPET/MRIを用いた画像情報の統合解析

肺癌の免疫治療における腫瘍免疫機能とPET/MRIを用いた画像情報の統合解析
肺癌免疫治疗中PET/MRI肿瘤免疫功能与影像信息综合分析
批准号:
22K07688
负责人:
梅田 幸寛
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2022
资助国家:
日本
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
[方法]观察ICI治疗前后外周血中性粒细胞/淋巴细胞比例及各血细胞成分、外周血中Flt在脾等次级淋巴组织和骨髓等造血组织中的积聚情况,探讨其与ICI疗效的关系。[结果]中位年龄70.4岁,男性23例(92%)。组织学类型分别为腺癌9例(36%),鳞癌11例(44%),其他4例(16%)。1例(4%)、7例(28%)、8例(32%)和9例(36%)患者分别得到CR、PR、SD和PD的确认应答。脾PD-1抑制剂治疗2周和6周后,SUV的中位数变化分别为5.44%和-4.72%。非帕金森病组与帕金森病组之间无显著差异(ΔSUV均值0-2 7.57vs.-3.61,P=0.6;ΔSUV均值0-6-5.28vs.3.44,P=0.69)。治疗开始两周后,非PD组和PD组之间任意胸椎(TH4、8和12)的18F-Flt PET参数(ΔSUVmax 0-2、ΔSUVean 0-2、ΔPPV/BSA0-2和ΔTVP/BSA0-2)的变化没有显著差异,尽管非PD组的18F-Flt积聚在治疗开始后2周有减少的趋势,而PD组的18F-Flt积聚有增加的趋势。非PD组治疗前至治疗后6周胸椎18F-Flt蓄积变化参数除ΔSUV均值为0~6外,均显著低于PD组。
英文摘要
【Methods】We evaluated the peripheral blood neutrophil-lymphocyte ratio and each blood cell component, and FLT accumulation in secondary lymphoid tissues such as spleen and hematopoietic tissues such as bone marrow, before and after ICI treatment , to determine their relationship to the therapeutic effect of ICI.【Results】The median age was 70.4 years, 23 (92%) were male. The histologic types were adenocarcinoma, squamous cell carcinoma, and others in nine (36%), 11 (44%), and four (16%) patients, respectively. Confirmed responses were CR, PR, SD, and PD in one (4%), seven (28%), eight (32%), and nine (36%) patients, respectively.The median changes of SUVs between baseline and two and six weeks after PD-1 inhibitor treatment for the spleen (ΔSUVmean0-2 and ΔSUVmean0-6) was 5.44% and -4.72%, respectively. These values did not differ significantly between the non-PD and PD groups (ΔSUVmean0-2 7.57 vs. -3.61, P = 0.60; ΔSUVmean0-6 -5.28 vs. 3.44, P = 0.69). The changes in any 18F-FLT PET parameters (ΔSUVmax0-2, ΔSUVmean0-2, ΔPPV/BSA0-2, and ΔTVP/BSA0-2) of any thoracic vertebrae (Th4, 8, and 12) between baseline and two weeks later were not significantly different between the non-PD and PD groups, although the 18F-FLT accumulation tended to decrease in the non-PD group and increase in the PD group two weeks after treatment initiation. All parameters of change of 18F-FLT accumulation in the thoracic vertebrae between baseline and 6 weeks after treatment initiation, except ΔSUVmean0-6 in Th4, were significantly lower in the non-PD group than in the PD group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
肠道菌群调控雌激素代谢在绝经后女性肺癌发生发展中的作用机制和靶向干预策略
  • 批准号:
    2026JJ50435
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    唐敬群
  • 依托单位:
HMGB3驱动肺癌脑转移及其在TTFields联合放疗中的调控作用与机制研究
  • 批准号:
    2026JJ50316
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周蓉蓉
  • 依托单位:
靶向LDHB激活cGAS-STING通路增强肺癌免疫治疗应答的作用及其机制研究
  • 批准号:
    2026JJ60084
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    邓海斌
  • 依托单位:
基于虚拟现实技术的肺癌患者围术期症状群多模态干预系统的构建及应用研究